Literature DB >> 9853567

Malignant insulinoma presenting a non-functioning metastatic liver tumor 14 years after resection of the primary tumor.

M Kobayashi1, S Kawa, M Kobayashi1, Y Imai, T Sodeyama, K Kiyosawa.   

Abstract

A 58-year-old woman who had undergone resection of insulinoma 14 year earlier visited our clinic complaining of abdominal discomfort. Computerized tomographic scan showed multiple liver tumors, and a diagnosis of metastatic tumor of malignant islet cell tumor was confirmed histologically. No oversecretion of hormones or hypoglycemic episode was observed on readmission. Thus, the insulinoma seemed to have transformed to a clinically non-functioning tumor. The patient was treated with transcatheter arterial embolization, resulting in clinical improvement with marked reduction in tumor size. Features of interest in this case included; (1) transformation to non-functioning metastatic liver tumor 14 years after resection of insulinoma, (2) the usefulness of transcatheter arterial embolization for multiple metastatic tumor of malignant islet cell tumor.

Entities:  

Mesh:

Year:  1998        PMID: 9853567     DOI: 10.1007/s005350050195

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  3 in total

Review 1.  Malignant insulinoma: spectrum of unusual clinical features.

Authors:  Boaz Hirshberg; Craig Cochran; Monica C Skarulis; Steven K Libutti; H Richard Alexander; Bradford J Wood; Richard Chang; David E Kleiner; Phillip Gorden
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

2.  Symptomatic hepatic metastasis of insulinoma 15 years after pancreatic resection.

Authors:  Samet Yardımcı; İlter Özer; Tahsin Dalgıç; Nesrin Turhan; Erdal Birol Bostancı
Journal:  Turk J Surg       Date:  2018-01-03

3.  Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.

Authors:  Aya Maekawa; Atsushi Kudo; Mitsuhiro Kishino; Yoshiki Murase; Shuichi Watanabe; Yoshiya Ishikawa; Hiroki Ueda; Keiichi Akahoshi; Kosuke Ogawa; Hiroaki Ono; Shinji Tanaka; Yuko Kinowaki; Minoru Tanabe
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-27       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.